Cargando…
SAT525 Long-Term Outcomes in Stage I Thyroid Cancer Without Radioiodine Remnant Ablation
Disclosure: F. Mubeen: None. M. Zahid: None. T.D. Cubb: None. J. Shakil: None. J. Xu: None. R.J. Robbins: None. Introduction: Although differentiated thyroid cancer (DTC) has low mortality, the risk of recurrence after thyroidectomy is not negligible. In the past radioiodine was routinely given to a...
Autores principales: | Mubeen, Faiza, Zahid, Maleeha, Cubb, Trisha D, Shakil, Jawairia, Xu, Jiaqiong, Robbins, Richard J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553410/ http://dx.doi.org/10.1210/jendso/bvad114.1997 |
Ejemplares similares
-
Lenvatinib-Induced Destructive Thyroiditis in a Patient With Hepatocellular Carcinoma
por: Pandya, Anjani, et al.
Publicado: (2021) -
SAT-410 Long Term Evaluation of TSH Receptor Antibodies and Thyroid Stimulating Immunoglobulin After Radioiodine Therapy for Thyrotoxicosis
por: Marui, Suemi, et al.
Publicado: (2020) -
SAT480 Diagnosing Dysphagia Due to Thyroid Nodules by Thyroid Ultrasound and the Effectiveness of Radiofrequency Ablation
por: Idrees, Zarwa, et al.
Publicado: (2023) -
MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020) -
SAT497 Radiofrequency Ablation of Thyroid Cancer in A Patient With Steinert’s Disease
por: Solis Pazmiño, Andrea Paola, et al.
Publicado: (2023)